Picture EBD Group Digital Medicine & Medtech Showcase 2021 at BTS2021 651x81
Document › Details

Mologen AG. (3/14/18). "Press Release: Successful Capital Increase with Gross Proceeds of €4.99 Million [Not for release, publication or distribution in or into United States, Australia, Canada or Japan, or any other jurisditcion in which unlawful]". Ber

Organisations Organisation Mologen AG
  Group Mologen (Group)
  Organisation 2 Donau Invest Beteiligungs Ges.m.b.H.
Products Product lefitolimod (MGN1703)
  Product 2 venture capital
Index term Index term Mologen–SEVERAL: investment, 201802–201803 capital increase €4.99m with 2.36m new shares at €2.12/share to existing + new investors
Persons Person Miller, Walter (Mologen 201604– CFO before Nuvisan Gmbh + Santhera Pharmaceuticals)
  Person 2 Nickolaus, Claudia (Mologen 201407– Head Investor Relations)

Record changed: 2018-03-31


Picture [iito] Plain Stupid Simple 650x80px

More documents for Mologen (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BioTech Showcase 2021 Digital Event BTS2021 651x81

» top